Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo

Enrico Caserta1, Onur Egriboz1, Hui Wang1

  • 1Solid Tumor Biology Program, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA; Department of Molecular Genetics, College of Arts and Sciences, The Ohio State University, Columbus, Ohio 43210, USA; Department of Molecular Virology, Immunology, and Medical Genetics, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA;

Genes & Development
|August 26, 2015
PubMed

Insights

A phosphatase and tensin homology deleted on chromosome 10 (PTEN) mutation, Pten(FV), impacts tumor suppression independently of AKT signaling. This study reveals organ-selective cancer development linked to this PTEN mutation in mice.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Inactivation of phosphatase and tensin homology deleted on chromosome 10 (PTEN) is a known driver of cancer via increased PI3K-AKT signaling.
  • PTEN's tumor suppressor role is critical in regulating cell growth and preventing tumorigenesis.

Purpose of the Study:

  • To investigate the in vivo tumor suppressor function of a PTEN C2 domain missense mutation (Pten(FV)), identified in human cancers.
  • To determine if this mutation affects AKT signaling and leads to organ-selective cancer development.

Main Methods:

  • Generation and analysis of Pten knock-in mice harboring the Pten(FV) mutation.
  • Assessment of AKT signaling pathways in Pten(FV/FV) and Pten(FV/+) mice.
  • Histopathological examination of various organs for carcinoma development.

Main Results:

  • Homozygous Pten(FV/FV) embryos showed normal development despite reduced PTEN protein and intact AKT signaling.
  • Heterozygous Pten(FV/+) mice developed carcinoma in specific organs (thymus, stomach, adrenal medulla, mammary gland) but not others.
  • Tumor progression in sensitive organs occurred without overt AKT activation, while uterine cancer required secondary AKT activation.

Conclusions:

  • The Pten(FV) mutation exhibits a tumor suppressor function independent of canonical AKT signaling inhibition.
  • This PTEN mutation predisposes to organ-selective cancer development through mechanisms distinct from AKT pathway activation.
  • Understanding this novel tumor suppressor function is crucial for targeted cancer therapies.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K